The wait is over! Our new filler is here!
JUVÉDERM® VOLUX™ XC IS NOW AVAILABLE!
We’re excited to announce JUVÉDERM® VOLUX™ XC, the latest innovation to the JUVÉDERM® Collection of Fillers, has finally arrived!
JUVÉDERM® VOLUX™ XC is the first and only FDA-approved hyaluronic acid filler for improving lost jawline definition, so you can:
|achieve a more contoured jawline|
|see immediate and long-lasting results|
|love your look from every angle!|
IMMEDIATE AND LONG-LASTING JAWLINE DEFINITION*
|†||In the JUVÉDERM® VOLUMA® XC clinical study in the chin, the main measure for clinical study success was not met in men or patients aged 51.5 years and older, however, their satisfaction was still high.|
Contact our office at
to schedule your consultation—
and love your look from every angle.
|*||70% of participants in the treatment group showed improvement in jawline definition at 6 months, with 61% showing long-lasting results through 1 year, with optimal treatment.|
JUVÉDERM® VOLUMA® XC and JUVÉDERM® VOLUX™ XC Injectable Gel Important Information
JUVÉDERM® VOLUX™ XC injectable gel is for deep injection to improve moderate to severe loss of jawline definition in adults over the age of 21.
JUVÉDERM® VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to improve the chin profile in adults over 21.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive any JUVÉDERM® formulation?
Do not use if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or the Gram-positive bacterial proteins used in these products, or if you have had previous allergic reactions to hyaluronic acid fillers.
What warnings should my doctor advise me about?
|•||One of the risks with using dermal fillers is the unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. Most of these events are irreversible.|
|•||If you have changes in your vision, signs of a stroke (including sudden difficulty speaking, numbness or weakness in your face, arms or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion), white appearance of the skin, or unusual pain during or shortly after treatment, you should notify your health care practitioner immediately.|
|•||The use of dermal fillers where skin sores, pimples, rashes, hives, cysts, or infections are present should be postponed until healing is complete, as these could delay healing or make your skin problems worse.|
|•||The effectiveness of removal of any dermal filler has not been studied.|
What precautions should my doctor advise me about?
|•||Avoid applying makeup for 12 hours after treatment and minimize strenuous exercise and exposure to extensive sun or heat within the first 24 hours following treatment. Exposure to any of these may cause temporary redness, swelling, and/or itching at the injection site|
|•||Tell your doctor if you are pregnant or breastfeeding. The safety of these products for use during pregnancy or while breastfeeding has not been studied|
|•||The safety of JUVÉDERM® VOLUMA® XC has not been studied in patients under 35 years or over 65 years for cheek augmentation, or under 22 years and over 80 years for chin augmentation|
|•||The safety and effectiveness of treatment with JUVÉDERM® products in anatomical regions outside of their approved uses have not been established in clinical studies|
|•||Tell your doctor if you have a history of excessive scarring (thick, hard scars) or pigmentation disorders. The safety of JUVÉDERM® VOLUMA® XC and JUVÉDERM® VOLUX™ XC in patients with a history of excessive scarring or pigmentation disorders has not been studied. Use in these patients may result in additional scars or changes in pigmentation|
|•||Tell your doctor if you are on therapy used to reduce your body’s natural defense system (such as steroids, chemotherapy, and medicines to treat autoimmune diseases, HIV, and AIDs), as these may increase your risk of infection; and medications that can prolong bleeding (such as aspirin, ibuprofen, or other blood thinners), as these may result in increased bruising or bleeding at the injection site|
|•||JUVÉDERM® VOLUMA® XC was not studied in patients with significant loose skin of the chin, neck, or jaw|
|•||The effect of JUVÉDERM® VOLUMA® XC injection into the chin on facial hair growth has not been studied|
|•||If you are planning other procedures including laser treatments or a chemical peel, there is a possible risk of inflammation at the treatment site if these procedures are performed closely before or after JUVÉDERM® injectable gel treatment|
|•||Tell your doctor if you have already been injected with dermal fillers in the same area as the one(s) you are about to be treated for|
What are possible side effects?
The most common reported side effects with JUVÉDERM® VOLUMA® XC and JUVÉDERM® VOLUX™ XC were tenderness, swelling, firmness, lumps/bumps, bruising, redness, pain, discoloration, and itching. For JUVÉDERM® VOLUMA® XC, side effects were usually moderate in severity and lasted 2 to 4 weeks. For JUVÉDERM® VOLUX™ XC, side effects were usually mild or moderate in severity and lasted up to 2 weeks although 35% lasted up to 30 days.
Your doctor may choose to treat side effects persisting over 30 days with antibiotics, steroids, or hyaluronidase (an enzyme that breaks down hyaluronic acid).
As with all skin injection procedures, there is a risk of infection.
To report a side effect with any product in the JUVÉDERM® Collection, please call the Allergan® Product Support Department at 1-877-345-5372. Please also visit Juvederm.com or talk to your doctor for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician or properly licensed practitioner.
© 2023 AbbVie. All rights reserved. JUVÉDERM, VOLUX, VOLUMA, and their designs are trademarks of Allergan Holdings France SAS, an AbbVie company, or its affiliates.